Serum ischemia-modified albumin level returns to its premenopausal level with 1-year hormone therapy in healthy menopausal women


Creative Commons License

Cetin E. C. , GÜVEN S., Sal H., Guven E. S. , MENTEŞE A.

MENOPAUSE REVIEW-PRZEGLAD MENOPAUZALNY, vol.20, no.2, pp.76-80, 2021 (Peer-Reviewed Journal) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 20 Issue: 2
  • Publication Date: 2021
  • Doi Number: 10.5114/pm.2021.106089
  • Journal Name: MENOPAUSE REVIEW-PRZEGLAD MENOPAUZALNY
  • Journal Indexes: Emerging Sources Citation Index, Scopus, Academic Search Premier, EMBASE, Directory of Open Access Journals
  • Page Numbers: pp.76-80
  • Keywords: IMA, menopause, hormone therapy, cardiovascular risk, ESTROGEN PLUS PROGESTIN, POSTMENOPAUSAL WOMEN, ENDOTHELIAL FUNCTION, REPLACEMENT THERAPY, PREVENTION, ESTRADIOL, RISK

Abstract

Introduction: To assess the effect of hormone therapy (HT) on serum ischemia modified albumin (IMA) levels in healthy menopausal women.